You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prediction of True Oligo-metastatic Disease.

Recruiting
  • Oligometastatic Disease
  • Genetic and immunologic assessments
  • Naples, Italy
    Alessandro Ottaiano
Apr 7, 2023

MiRNA in Detecting Active Germ Cell Tumors in Early Suspected

Recruiting
  • Malignant Testicular Germ Cell Tumor
  • Non-Interventional Study
  • Los Angeles, California
  • +1 more
Sep 28, 2023

Luminal Metastatic breAst caNcer in Real-life Clinical pracTice

Completed
  • HR+/HER2- Breast Cancer
  • +2 more
  • Moscow, Russian Federation
    Russian Society of Clinical Oncology
Mar 29, 2023

Metastatic Cancer Trial in La Jolla (CBI, CBI plus SBRT)

Active, not recruiting
  • Metastatic Cancer
  • La Jolla, California
    UCSD Moores Cancer Center
May 16, 2022

Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen

Recruiting
  • Advanced Cholangiocarcinoma
  • +6 more
  • Biospecimen Collection
  • +3 more
  • Los Angeles, California
  • +1 more
Mar 31, 2023

Metastatic Breast Cancer, Breast Cancer Stage IV Trial in São Paulo

Recruiting
  • Metastatic Breast Cancer
  • Breast Cancer Stage IV
    • São Paulo, SP, Brazil
      Hcor
    Sep 26, 2022

    Oligometastatic Hormone Sensitive Prostate Cancer Trial in Florence (SBRT on all sites of metastatic disease+Apalutamide)

    Not yet recruiting
    • Oligometastatic Hormone Sensitive Prostate Cancer
    • SBRT on all sites of metastatic disease+Apalutamide
    • Florence, Italy
      AOU Careggi Radiation Oncology Unit
    Jan 29, 2023

    Breast Cancer Trial in Sydney ([68Ga]GA-NeoB)

    Recruiting
    • Breast Cancer
    • Sydney, New South Wales, Australia
      St Vincent's Hospital
    May 22, 2023

    Metastatic Cancer Trial in London (Stereotactic ablative radiotherapy - Level 1, Stereotactic ablative radiotherapy - Level 2,

    Recruiting
    • Metastatic Cancer
    • Stereotactic ablative radiotherapy - Level 1
    • +4 more
    • London, Ontario, Canada
      London Health Sciences Centre - London Regional Cancer Program
    Apr 4, 2022

    Oligometastasis, Metastatic Cancer Trial in Cary, Durham, Raleigh

    Recruiting
    • Oligometastasis
    • Metastatic Cancer
      • Cary, North Carolina
      • +4 more
      Apr 21, 2022

      Colorectal Carcinoma, Liver Metastases Trial in Copenhagen (MWA, SBRT)

      Recruiting
      • Colorectal Carcinoma
      • Liver Metastases
      • MWA
      • SBRT
      • Copenhagen, Denmark
        Righospitalet
      Jan 21, 2022

      Malignant Tumor of Prostate Trial in Cleveland ([F-18] NaF PET/CT, [F-18] fluciclovine PET/CT)

      Withdrawn
      • Malignant Neoplasm of Prostate
      • [F-18] NaF PET/CT
      • [F-18] fluciclovine PET/CT
      • Cleveland, Ohio
        University Hospitals Cleveland Medical Center, Case Comprehensiv
      Mar 21, 2022

      Pancreatic Cancer, Advanced Cancer, Metastatic Cancer Trial in Beijing (Later-line therapy)

      Recruiting
      • Pancreatic Cancer
      • +2 more
      • Later-line therapy
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Apr 10, 2023

      Culture of Circulating Tumor Cells Isolated From Cancer

      Completed
      • Circulating Tumor Cells
      • Blood draw
      • Chapel Hill, North Carolina
        University of North Carolina at Chapel Hill, Department of Radia
      Dec 21, 2021

      Thyroid Cancer Trial in Medellin (Traditional neck dissection approach, Anterior neck dissection approach)

      Recruiting
      • Thyroid Cancer
      • Traditional neck dissection approach
      • Anterior neck dissection approach
      • Medellin, Antioquia, Colombia
        Hospital Alma Mater de Antioquia
      Nov 20, 2023

      Metastatic Pancreatic Cancer Trial in Rotterdam (MesoPher, Mitazalimab)

      Recruiting
      • Metastatic Pancreatic Cancer
      • MesoPher
      • Mitazalimab
      • Rotterdam, Zuid-Holland, Netherlands
        Erasmus MC
      Dec 6, 2022

      Colorectal Cancer Metastatic Disease in Middle-Norway

      Active, not recruiting
      • Neoplasms, Colorectal
      • Neoplasm Metastasis
      • cancer treatment and follow-up according to current regional and national guidelines
      • Kristiansund, Norway
      • +6 more
      Feb 10, 2022

      Breast Cancer Trial in New York (Multicomponent Adherence Intervention)

      Recruiting
      • Breast Cancer
      • Multicomponent Adherence Intervention
      • New York, New York
        Columbia University Medical Center
      Nov 6, 2023

      Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

      Recruiting
      • Adenocarcinoma
      • +8 more
      • Radiotherapy targeted to the primary lesion
      • +7 more
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Nov 7, 2023

      DESTINY Breast Respond HER2-low Europe

      Not yet recruiting
      • Unresectable Breast Cancer
      • +2 more
      • Trastuzumab deruxtecan
      • (no location specified)
      Jul 6, 2023

      Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)

      Not yet recruiting
      • Unresectable Metastatic Colorectal Cancer
      • (no location specified)
      Oct 25, 2023

      Metastatic Cancer, Solid Tumor Cancer, Lymphoproliferative Disorders Trial in Boulder (Written Exposure Therapy)

      Recruiting
      • Metastatic Cancer
      • +5 more
      • Written Exposure Therapy
      • Boulder, Colorado
        University of Colorado Boulder
      Sep 13, 2023

      Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in

      Not yet recruiting
      • Metastatic Castration-resistant Prostate Cancer
      • +2 more
      • Vancouver, British Columbia, Canada
        BC Cancer
      Nov 28, 2022

      Metastatic Colorectal Cancer Trial (Anti-PD-1 Monoclonal Antibody + Capecitabine)

      Not yet recruiting
      • Metastatic Colorectal Cancer
      • Tislelizumab + Capecitabine
      • Best supportive care
      • (no location specified)
      Sep 22, 2022

      Leptomeningeal Disease Trial in Germany (Nivolumab [Opdivo])

      Recruiting
      • Leptomeningeal Disease
      • Nivolumab [Opdivo]
      • Freiburg, Germany
      • +6 more
      Nov 2, 2022